Global and China Oligonucleotide Synthesis Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotide Synthesis Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Synthesized Oligonucleotides
1.2.3 Reagents
1.2.4 Equipment
1.3 Market by Application
1.3.1 Global Oligonucleotide Synthesis Market Share by Application: 2020 VS 2026
1.3.2 PCR
1.3.3 DNA
1.3.4 RNAi
1.3.5 Research
1.3.6 Therapeutic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide Synthesis Market Perspective (2015-2026)
2.2 Global Oligonucleotide Synthesis Growth Trends by Regions
2.2.1 Oligonucleotide Synthesis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Oligonucleotide Synthesis Historic Market Share by Regions (2015-2020)
2.2.3 Oligonucleotide Synthesis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotide Synthesis Players by Market Size
3.1.1 Global Top Oligonucleotide Synthesis Players by Revenue (2015-2020)
3.1.2 Global Oligonucleotide Synthesis Revenue Market Share by Players (2015-2020)
3.2 Global Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oligonucleotide Synthesis Revenue
3.4 Global Oligonucleotide Synthesis Market Concentration Ratio
3.4.1 Global Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Synthesis Revenue in 2019
3.5 Key Players Oligonucleotide Synthesis Area Served
3.6 Key Players Oligonucleotide Synthesis Product Solution and Service
3.7 Date of Enter into Oligonucleotide Synthesis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotide Synthesis Breakdown Data by Type (2015-2026)
4.1 Global Oligonucleotide Synthesis Historic Market Size by Type (2015-2020)
4.2 Global Oligonucleotide Synthesis Forecasted Market Size by Type (2021-2026)
5 Oligonucleotide Synthesis Breakdown Data by Application (2015-2026)
5.1 Global Oligonucleotide Synthesis Historic Market Size by Application (2015-2020)
5.2 Global Oligonucleotide Synthesis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Oligonucleotide Synthesis Market Size (2015-2026)
6.2 North America Oligonucleotide Synthesis Market Size by Type (2015-2020)
6.3 North America Oligonucleotide Synthesis Market Size by Application (2015-2020)
6.4 North America Oligonucleotide Synthesis Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Oligonucleotide Synthesis Market Size (2015-2026)
7.2 Europe Oligonucleotide Synthesis Market Size by Type (2015-2020)
7.3 Europe Oligonucleotide Synthesis Market Size by Application (2015-2020)
7.4 Europe Oligonucleotide Synthesis Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Oligonucleotide Synthesis Market Size (2015-2026)
8.2 China Oligonucleotide Synthesis Market Size by Type (2015-2020)
8.3 China Oligonucleotide Synthesis Market Size by Application (2015-2020)
8.4 China Oligonucleotide Synthesis Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Oligonucleotide Synthesis Market Size (2015-2026)
9.2 Japan Oligonucleotide Synthesis Market Size by Type (2015-2020)
9.3 Japan Oligonucleotide Synthesis Market Size by Application (2015-2020)
9.4 Japan Oligonucleotide Synthesis Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Oligonucleotide Synthesis Market Size (2015-2026)
10.2 Southeast Asia Oligonucleotide Synthesis Market Size by Type (2015-2020)
10.3 Southeast Asia Oligonucleotide Synthesis Market Size by Application (2015-2020)
10.4 Southeast Asia Oligonucleotide Synthesis Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Integrated DNA Technologies
11.1.1 Integrated DNA Technologies Company Details
11.1.2 Integrated DNA Technologies Business Overview
11.1.3 Integrated DNA Technologies Oligonucleotide Synthesis Introduction
11.1.4 Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2015-2020))
11.1.5 Integrated DNA Technologies Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Oligonucleotide Synthesis Introduction
11.2.4 Merck KGaA Revenue in Oligonucleotide Synthesis Business (2015-2020)
11.2.5 Merck KGaA Recent Development
11.3 Eurofins Genomics
11.3.1 Eurofins Genomics Company Details
11.3.2 Eurofins Genomics Business Overview
11.3.3 Eurofins Genomics Oligonucleotide Synthesis Introduction
11.3.4 Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2015-2020)
11.3.5 Eurofins Genomics Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Oligonucleotide Synthesis Introduction
11.4.4 Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2015-2020)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Bioautomation
11.5.1 Bioautomation Company Details
11.5.2 Bioautomation Business Overview
11.5.3 Bioautomation Oligonucleotide Synthesis Introduction
11.5.4 Bioautomation Revenue in Oligonucleotide Synthesis Business (2015-2020)
11.5.5 Bioautomation Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Details
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Oligonucleotide Synthesis Introduction
11.6.4 Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2015-2020)
11.6.5 Agilent Technologies Recent Development
11.7 Eurogentec
11.7.1 Eurogentec Company Details
11.7.2 Eurogentec Business Overview
11.7.3 Eurogentec Oligonucleotide Synthesis Introduction
11.7.4 Eurogentec Revenue in Oligonucleotide Synthesis Business (2015-2020)
11.7.5 Eurogentec Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Oligonucleotide Synthesis Introduction
11.8.4 GE Healthcare Revenue in Oligonucleotide Synthesis Business (2015-2020)
11.8.5 GE Healthcare Recent Development
11.9 LGC Biosearch Technologies
11.9.1 LGC Biosearch Technologies Company Details
11.9.2 LGC Biosearch Technologies Business Overview
11.9.3 LGC Biosearch Technologies Oligonucleotide Synthesis Introduction
11.9.4 LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2015-2020)
11.9.5 LGC Biosearch Technologies Recent Development
11.10 Nitto Denko Avecia
11.10.1 Nitto Denko Avecia Company Details
11.10.2 Nitto Denko Avecia Business Overview
11.10.3 Nitto Denko Avecia Oligonucleotide Synthesis Introduction
11.10.4 Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2015-2020)
11.10.5 Nitto Denko Avecia Recent Development
11.11 Genscript
10.11.1 Genscript Company Details
10.11.2 Genscript Business Overview
10.11.3 Genscript Oligonucleotide Synthesis Introduction
10.11.4 Genscript Revenue in Oligonucleotide Synthesis Business (2015-2020)
10.11.5 Genscript Recent Development
11.12 Genedesign
10.12.1 Genedesign Company Details
10.12.2 Genedesign Business Overview
10.12.3 Genedesign Oligonucleotide Synthesis Introduction
10.12.4 Genedesign Revenue in Oligonucleotide Synthesis Business (2015-2020)
10.12.5 Genedesign Recent Development
11.13 TriLink Biotechnologies
10.13.1 TriLink Biotechnologies Company Details
10.13.2 TriLink Biotechnologies Business Overview
10.13.3 TriLink Biotechnologies Oligonucleotide Synthesis Introduction
10.13.4 TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2015-2020)
10.13.5 TriLink Biotechnologies Recent Development
11.14 Bio-Synthesis
10.14.1 Bio-Synthesis Company Details
10.14.2 Bio-Synthesis Business Overview
10.14.3 Bio-Synthesis Oligonucleotide Synthesis Introduction
10.14.4 Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2015-2020)
10.14.5 Bio-Synthesis Recent Development
11.15 ATDBio
10.15.1 ATDBio Company Details
10.15.2 ATDBio Business Overview
10.15.3 ATDBio Oligonucleotide Synthesis Introduction
10.15.4 ATDBio Revenue in Oligonucleotide Synthesis Business (2015-2020)
10.15.5 ATDBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Synthesized Oligonucleotides
Table 4. Key Players of Reagents
Table 5. Key Players of Equipment
Table 6. Global Oligonucleotide Synthesis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Oligonucleotide Synthesis Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Oligonucleotide Synthesis Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Oligonucleotide Synthesis Market Share by Regions (2015-2020)
Table 10. Global Oligonucleotide Synthesis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Oligonucleotide Synthesis Market Share by Regions (2021-2026)
Table 12. Oligonucleotide Synthesis Market Market Trends
Table 13. Oligonucleotide Synthesis Market Drivers
Table 14. Oligonucleotide Synthesis Market Challenges
Table 15. Oligonucleotide Synthesis Market Restraints
Table 16. Global Oligonucleotide Synthesis Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Oligonucleotide Synthesis Market Share by Players (2015-2020)
Table 18. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide Synthesis as of 2019)
Table 19. Global Oligonucleotide Synthesis by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oligonucleotide Synthesis Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oligonucleotide Synthesis Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Oligonucleotide Synthesis Market Size Share by Type (2015-2020)
Table 25. Global Oligonucleotide Synthesis Revenue Market Share by Type (2021-2026)
Table 26. Global Oligonucleotide Synthesis Market Size Share by Application (2015-2020)
Table 27. Global Oligonucleotide Synthesis Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Oligonucleotide Synthesis Market Size Share by Application (2021-2026)
Table 29. North America Oligonucleotide Synthesis Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Oligonucleotide Synthesis Market Share by Type (2015-2020)
Table 31. North America Oligonucleotide Synthesis Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Oligonucleotide Synthesis Market Share by Application (2015-2020)
Table 33. North America Oligonucleotide Synthesis Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Oligonucleotide Synthesis Market Share by Country (2015-2020)
Table 35. Europe Oligonucleotide Synthesis Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Oligonucleotide Synthesis Market Share by Type (2015-2020)
Table 37. Europe Oligonucleotide Synthesis Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Oligonucleotide Synthesis Market Share by Application (2015-2020)
Table 39. Europe Oligonucleotide Synthesis Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Oligonucleotide Synthesis Market Share by Country (2015-2020)
Table 41. China Oligonucleotide Synthesis Market Size by Type (2015-2020) (US$ Million)
Table 42. China Oligonucleotide Synthesis Market Share by Type (2015-2020)
Table 43. China Oligonucleotide Synthesis Market Size by Application (2015-2020) (US$ Million)
Table 44. China Oligonucleotide Synthesis Market Share by Application (2015-2020)
Table 45. China Oligonucleotide Synthesis Market Size by Region (US$ Million) (2015-2020)
Table 46. China Oligonucleotide Synthesis Market Share by Region (2015-2020)
Table 47. Japan Oligonucleotide Synthesis Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Oligonucleotide Synthesis Market Share by Type (2015-2020)
Table 49. Japan Oligonucleotide Synthesis Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Oligonucleotide Synthesis Market Share by Application (2015-2020)
Table 51. Japan Oligonucleotide Synthesis Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Oligonucleotide Synthesis Market Share by Country (2015-2020)
Table 53. Southeast Asia Oligonucleotide Synthesis Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Oligonucleotide Synthesis Market Share by Type (2015-2020)
Table 55. Southeast Asia Oligonucleotide Synthesis Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Oligonucleotide Synthesis Market Share by Application (2015-2020)
Table 57. Southeast Asia Oligonucleotide Synthesis Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Oligonucleotide Synthesis Market Share by Country (2015-2020)
Table 59. Integrated DNA Technologies Company Details
Table 60. Integrated DNA Technologies Business Overview
Table 61. Integrated DNA Technologies Product
Table 62. Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 63. Integrated DNA Technologies Recent Development
Table 64. Merck KGaA Company Details
Table 65. Merck KGaA Business Overview
Table 66. Merck KGaA Product
Table 67. Merck KGaA Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 68. Merck KGaA Recent Development
Table 69. Eurofins Genomics Company Details
Table 70. Eurofins Genomics Business Overview
Table 71. Eurofins Genomics Product
Table 72. Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 73. Eurofins Genomics Recent Development
Table 74. Thermo Fisher Scientific Company Details
Table 75. Thermo Fisher Scientific Business Overview
Table 76. Thermo Fisher Scientific Product
Table 77. Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 78. Thermo Fisher Scientific Recent Development
Table 79. Bioautomation Company Details
Table 80. Bioautomation Business Overview
Table 81. Bioautomation Product
Table 82. Bioautomation Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 83. Bioautomation Recent Development
Table 84. Agilent Technologies Company Details
Table 85. Agilent Technologies Business Overview
Table 86. Agilent Technologies Product
Table 87. Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 88. Agilent Technologies Recent Development
Table 89. Eurogentec Company Details
Table 90. Eurogentec Business Overview
Table 91. Eurogentec Product
Table 92. Eurogentec Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 93. Eurogentec Recent Development
Table 94. GE Healthcare Business Overview
Table 95. GE Healthcare Product
Table 96. GE Healthcare Company Details
Table 97. GE Healthcare Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 98. GE Healthcare Recent Development
Table 99. LGC Biosearch Technologies Company Details
Table 100. LGC Biosearch Technologies Business Overview
Table 101. LGC Biosearch Technologies Product
Table 102. LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 103. LGC Biosearch Technologies Recent Development
Table 104. Nitto Denko Avecia Company Details
Table 105. Nitto Denko Avecia Business Overview
Table 106. Nitto Denko Avecia Product
Table 107. Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 108. Nitto Denko Avecia Recent Development
Table 109. Genscript Company Details
Table 110. Genscript Business Overview
Table 111. Genscript Product
Table 112. Genscript Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 113. Genscript Recent Development
Table 114. Genedesign Company Details
Table 115. Genedesign Business Overview
Table 116. Genedesign Product
Table 117. Genedesign Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 118. Genedesign Recent Development
Table 119. TriLink Biotechnologies Company Details
Table 120. TriLink Biotechnologies Business Overview
Table 121. TriLink Biotechnologies Product
Table 122. TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 123. TriLink Biotechnologies Recent Development
Table 124. Bio-Synthesis Company Details
Table 125. Bio-Synthesis Business Overview
Table 126. Bio-Synthesis Product
Table 127. Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 128. Bio-Synthesis Recent Development
Table 129. ATDBio Company Details
Table 130. ATDBio Business Overview
Table 131. ATDBio Product
Table 132. ATDBio Revenue in Oligonucleotide Synthesis Business (2015-2020) (US$ Million)
Table 133. ATDBio Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Oligonucleotide Synthesis Market Share by Type: 2020 VS 2026
Figure 2. Synthesized Oligonucleotides Features
Figure 3. Reagents Features
Figure 4. Equipment Features
Figure 5. Global Oligonucleotide Synthesis Market Share by Application: 2020 VS 2026
Figure 6. PCR Case Studies
Figure 7. DNA Case Studies
Figure 8. RNAi Case Studies
Figure 9. Research Case Studies
Figure 10. Therapeutic Case Studies
Figure 11. Oligonucleotide Synthesis Report Years Considered
Figure 12. Global Oligonucleotide Synthesis Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Oligonucleotide Synthesis Market Share by Regions: 2020 VS 2026
Figure 14. Global Oligonucleotide Synthesis Market Share by Regions (2021-2026)
Figure 15. Global Oligonucleotide Synthesis Market Share by Players in 2019
Figure 16. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide Synthesis as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Oligonucleotide Synthesis Revenue in 2019
Figure 18. North America Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Oligonucleotide Synthesis Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 46. Merck KGaA Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 47. Eurofins Genomics Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 49. Bioautomation Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 50. Agilent Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 51. Eurogentec Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 52. GE Healthcare Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 53. LGC Biosearch Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 54. Nitto Denko Avecia Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 55. Genscript Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 56. Genedesign Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 57. TriLink Biotechnologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 58. Bio-Synthesis Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 59. ATDBio Revenue Growth Rate in Oligonucleotide Synthesis Business (2015-2020)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed